v3.26.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Jun. 02, 2026
Jun. 30, 2025
Cover [Abstract]        
Document Type 10-K      
Amendment Flag false      
Document Annual Report true      
Document Transition Report false      
Document Period End Date Dec. 31, 2025      
Document Fiscal Period Focus FY      
Document Fiscal Year Focus 2025      
Current Fiscal Year End Date --12-31      
Entity File Number 001-39701      
Entity Registrant Name INVO FERTILITY, INC.      
Entity Central Index Key 0001417926      
Entity Tax Identification Number 20-4036208      
Entity Incorporation, State or Country Code NV      
Entity Address, Address Line One 5582 Broadcast Court      
Entity Address, City or Town Sarasota      
Entity Address, State or Province FL      
Entity Address, Postal Zip Code 34240      
City Area Code (978)      
Local Phone Number 878-9505      
Title of 12(b) Security Common Stock, $0.0001 par value per share      
Trading Symbol IVF      
Security Exchange Name NASDAQ      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company false      
Entity Shell Company false      
Entity Public Float       $ 2,185,985
Entity Common Stock, Shares Outstanding     1,786,035  
Documents Incorporated by Reference [Text Block] None.      
ICFR Auditor Attestation Flag false      
Document Financial Statement Error Correction [Flag] true      
Document Financial Statement Restatement Recovery Analysis [Flag] false      
Entity Listing, Par Value Per Share $ 0.0001      
Auditor Firm ID 100 2738    
Auditor Opinion [Text Block] We have audited the accompanying consolidated balance sheet of INVO Fertility, Inc. (the “Company”) as of December 31, 2025, and the related consolidated statements of operations, of Stockholders’ Equity and Mezzanine Equity, and of cash flows for year ended December 31, 2025, and the related notes to the consolidated financial statements (collectively referred to as the “consolidated financial statements”). In our opinion, the financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the year ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America. 

We also have audited the adjustments described in Note 1 that were applied to the recast of the December 31, 2024 consolidated balance sheet, consolidated statement of operations, and cash flows in relation to discontinued operations. In our opinion, such adjustments are appropriate and have been properly applied. We were not engaged to audit, review, or apply any procedures to the 2024 consolidated financial statements of the Company, other than with respect to the adjustment and, accordingly, we do not express an opinion or any other form of assurance on the 2024 consolidated financial statements taken as a whole.

  		     
Auditor Name WithumSmith+Brown, PC M&K CPAS, PLLC    
Auditor Location Irvine, CA The Woodlands, TX